1
Arnold Caplan, Glenn T Syftestad: Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites. Watts Hoffmann Fisher & Heinke, September 2, 1986: US04609551 (256 worldwide citation)

A process for exposing live cells to a soluble bone protein and transferring the cells into appropriate skeletal sites to initiate or enhance local chondrogenesis or osteogenesis. Isogenic fibroblasts are exposed in vitro to a soluble bone protein capable of stimulating in vitro and/or in vivo a cho ...


2
Arnold Caplan, Glenn T Syftestad: Bone protein purification process. Watts Hoffmann Fisher & Heinke Co, August 26, 1986: US04608199 (69 worldwide citation)

A process of extracting and purifying a bone protein capable of stimulating chondrogenic expression in undifferentiated cells in culture. The purification process is monitored at various stages by bioassaying the bone protein for chondrogenic activity in embryonic limb bud mesenchymal cell cultures.


3
Daniel Asselineau, Arnold Caplan: Antibodies specific for papillary fibroblasts as markers for skin quality. Norman H Stepno Esquire, Burns Doane Swecker & Mathis, November 1, 2001: US20010036642-A1

Whether or not a sample of skin or of a skin equivalent contains such amount of a papillary fibroblast population as to be considered a normal skin is determined by labelling said skin or skin equivalent with at least one antibody specific for papillary fibroblasts and evaluating the extent of such ...


4
Daniel Asselineau, Arnold Caplan: Antibodies specific for papillary fibroblasts as markers for skin quality. Burns Doane Swecker & Mathis, April 29, 2004: US20040082016-A1

Whether or not a sample of skin or of a skin equivalent contains such amount of a papillary fibroblast population as to be considered a normal skin is determined by labelling said skin or skin equivalent with at least one antibody specific for papillary fibroblasts and evaluating the extent of such ...


5
Daniel Asselineau, Arnold Caplan: Antibodies specific for papillary fibroblasts as markers for skin quality. L Oreal, Buchanan Ingersoll P C, March 20, 2007: US07192719

Whether or not a sample of skin or of a skin equivalent contains such amount of a papillary fibroblast population as to be considered a normal skin is determined by labelling said skin or skin equivalent with at least one antibody specific for papillary fibroblasts and evaluating the extent of such ...